Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on Prevention and Treatment of Recurrent and Metastasis of Triple Negative Breast Cancer(TNBC) With Traditional Chinese Medicine(TCM)

NCT03332368 is registered in ClinicalTrials.gov with Sheng Liu as lead sponsor.

NCT NCT03332368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03332368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on Prevention and Treatment of Recurrent and Metastasis of Triple Negative Breast Cancer(TNBC) With Traditional Chinese Medicine(TCM)
Lead sponsor
Sheng Liu
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2017
Completion date
January 1, 2019
Enrollment
620 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

overall survival, progression-free-survival, recurrence